Abstract
Purpose
Mild traumatic brain injury (mTBI) is a global public health problem and its current management is limited to rest and symptom management. Despite frequent use of drugs for symptom control, there is a lack of consensus on the optimal pharmacological management of post-concussive symptoms. We reviewed the relevant literature to compile the evidence about the pharmaceutical management of pediatric mTBI.
Methods
We performed a systematic review of the literature available in PubMed, Cochrane CENTRAL, and ClinicalTrials.Gov as well as through citation tracing. A modified PICO framework was used for the construction of search strategy and eligibility criteria. Risk of bias was assessed using RoB-2 tool for randomized and ROBINS-I for non-randomized studies.
Results
A total of 6260 articles were screened for eligibility. After exclusions, a total of 88 articles received full text review. A total of 15 reports representing 13 studies (5 randomized clinical trials, 1 prospective randomized cohort study, 1 prospective cohort study, and 6 retrospective cohort studies) met the eligibility criteria and were included in the review. We identified 16 pharmacological interventions in a total of 931 pediatric patients with mTBI. Amytriptiline (n = 4), ondansetron (n = 3), melatonin (n = 3), metoclopramide (n = 2), magnesium (n = 2), and topiramate (n = 2) were investigated in multiple studies. All RCTs were relatively of small size (n ≤ 33/group).
Conclusion
The available evidence supporting pharmacological intervention in pediatric mild traumatic brain injury is scarce. We propose a framework to facilitate future collaborative research efforts to test and validate various pharmacological interventions for acute and persistent post-concussive symptoms in children.
Similar content being viewed by others
Data, materials, and code availability
The datasets generated and/or used during this systematic review are available from the corresponding author upon reasonable request.
References
Dewan MC, Rattani A, Gupta S et al (2019) Estimating the global incidence of traumatic brain injury. J Neurosurg 130:1080–1097. https://doi.org/10.3171/2017.10.JNS17352
Furlan JC, Radan MM, Tator CH (2020) A scoping review of registered clinical studies on mild traumatic brain injury and concussion (2000 to 2019). Neurosurgery 87:891–899. https://doi.org/10.1093/neuros/nyaa151
Larsen EL, Ashina H, Iljazi A et al (2019) Acute and preventive pharmacological treatment of post-traumatic headache: a systematic review. J Headache Pain 20:98. https://doi.org/10.1186/s10194-019-1051-7
Kim K, Priefer R (2020) Evaluation of current post-concussion protocols. Biomed Pharmacother 129:110406. https://doi.org/10.1016/j.biopha.2020.110406
Arbabi M, Sheldon R, Bahadoran P et al (2020) Treatment outcomes in mild traumatic brain injury: a systematic review of randomized controlled trials. Brain Inj 34:1139–1149. https://doi.org/10.1080/02699052.2020.1797168
Monsour DA, Lay C, Ansari T, Lagman-Bartolome AM (2020) Post-traumatic headache in children and adolescents: a narrative review with a focus on management. Curr Neurol Neurosci Rep 20:53. https://doi.org/10.1007/s11910-020-01068-w
Feinberg C, Carr C, Zemek R et al (2021) Association of pharmacological interventions with symptom burden reduction in patients with mild traumatic brain injury: a systematic review. JAMA Neurol. https://doi.org/10.1001/jamaneurol.2020.5079
Murray TR, Ferderer T, Gehred A, Rose SC (2021) Treatment of post-traumatic headaches in children: a systematic review. Semin Pediatr Neurol 40:100935. https://doi.org/10.1016/j.spen.2021.100935
Doll E, Gong P, Sowell M, Evanczyk L (2021) Post-traumatic headache in children and adolescents. Curr Pain Headache Rep 25:51. https://doi.org/10.1007/s11916-021-00967-y
Patterson Gentile C, Shah R, Irwin SL et al (2021) Acute and chronic management of posttraumatic headache in children: a systematic review. Headache 61:1475–1492. https://doi.org/10.1111/head.14236
Page MJ, McKenzie JE, Bossuyt PM et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ n71. https://doi.org/10.1136/bmj.n71
Sterne JAC, Savović J, Page MJ et al (2019) RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ 366:l4898. https://doi.org/10.1136/bmj.l4898
Sterne JA, Hernán MA, Reeves BC et al (2016) ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ 355:i4919. https://doi.org/10.1136/bmj.i4919
Barlow KM, Brooks BL, Esser MJ et al (2020) Efficacy of melatonin in children with postconcussive symptoms: a randomized clinical trial. Pediatrics 145. https://doi.org/10.1542/peds.2019-2812
Barlow KM, Kirk V, Brooks B et al (2021) Efficacy of melatonin for sleep disturbance in children with persistent post-concussion symptoms: secondary analysis of a randomized controlled trial. J Neurotrauma 38:950–959. https://doi.org/10.1089/neu.2020.7154
Petrelli T, Farrokhyar F, McGrath P et al (2017) The use of ibuprofen and acetaminophen for acute headache in the postconcussive youth: a pilot study. Paediatr Child Health 22:2–6. https://doi.org/10.1093/pch/pxw011
Chan S, Kurowski B, Byczkowski T, Timm N (2015) Intravenous migraine therapy in children with posttraumatic headache in the ED. Am J Emerg Med 33:635–639. https://doi.org/10.1016/j.ajem.2015.01.053
Gravel J, Carrière B, D’Angelo A et al (2017) Ondansetron for pediatric concussion; a pilot study for a randomized controlled trial. CJEM 19:338–346. https://doi.org/10.1017/cem.2016.369
Gravel J, Boutis K, Tang K et al (2019) Association between ondansetron use and symptom persistence in children with concussions: a 5P substudy. CJEM 21:204–210. https://doi.org/10.1017/cem.2018.384
Bresee N, Aglipay M, Dubrovsky AS et al (2018) No association between metoclopramide treatment in ED and reduced risk of post-concussion headache. Am J Emerg Med 36:2225–2231. https://doi.org/10.1016/j.ajem.2018.04.007
Lumba-Brown A, Yeates KO, Sarmiento K et al (2018) Centers for Disease Control and Prevention Guideline on the Diagnosis and Management of Mild Traumatic Brain Injury Among Children. JAMA Pediatr 172:e182853. https://doi.org/10.1001/jamapediatrics.2018.2853
Standiford L, O’Daniel M, Hysell M, Trigger C (2021) A randomized cohort study of the efficacy of PO magnesium in the treatment of acute concussions in adolescents. Am J Emerg Med 44:419–422. https://doi.org/10.1016/j.ajem.2020.05.010
Kuczynski A, Crawford S, Bodell L et al (2013) Characteristics of post-traumatic headaches in children following mild traumatic brain injury and their response to treatment: a prospective cohort. Dev Med Child Neurol 55:636–641. https://doi.org/10.1111/dmcn.12152
Heyer GL, Idris SA (2014) Does analgesic overuse contribute to chronic post-traumatic headaches in adolescent concussion patients? Pediatr Neurol 50:464–468. https://doi.org/10.1016/j.pediatrneurol.2014.01.040
Bramley H, Melinosky C, Silvis M, Ross S (2012) Pediatric posttraumatic headache: two cases using steroids as abortive therapy. Pediatr Emerg Care 28:1081–1084. https://doi.org/10.1097/PEC.0b013e31826ceeeb
Cushman DM, Borowski L, Hansen C et al (2019) Gabapentin and tricyclics in the treatment of post-concussive headache, a retrospective cohort study. Headache 59:371–382. https://doi.org/10.1111/head.13451
Reddy CC, Collins M, Lovell M, Kontos AP (2013) Efficacy of amantadine treatment on symptoms and neurocognitive performance among adolescents following sports-related concussion. J Head Trauma Rehabil 28:260–265. https://doi.org/10.1097/HTR.0b013e318257fbc6
Tramontana MG, Prokop JW, Williamson E et al (2021) Traumatic brain injury-related attention deficits in children: a controlled treatment trial with lisdexamfetamine dimesylate (vyvanse). Brain Sci 11:117. https://doi.org/10.3390/brainsci11010117
Bramley H, Heverley S, Lewis MM et al (2015) Demographics and treatment of adolescent posttraumatic headache in a regional concussion clinic. Pediatr Neurol 52:493–498. https://doi.org/10.1016/j.pediatrneurol.2015.01.008
Mahalick DM, Carmel PW, Greenberg JP et al (1998) Psychopharmacologic treatment of acquired attention disorders in children with brain injury. Pediatr Neurosurg 29:121–126. https://doi.org/10.1159/000028705
Beers SR, Skold A, Dixon CE, Adelson PD (2005) Neurobehavioral effects of amantadine after pediatric traumatic brain injury: a preliminary report. J Head Trauma Rehabil 20:450–463. https://doi.org/10.1097/00001199-200509000-00006
Mannix R, Zemek R, Yeates KO et al (2019) Practice patterns in pharmacological and non-pharmacological therapies for children with mild traumatic brain injury: a survey of 15 Canadian and United States centers. J Neurotrauma 36:2886–2894. https://doi.org/10.1089/neu.2018.6290
Lumba-Brown A, Harley J, Lucio S et al (2014) Hypertonic saline as a therapy for pediatric concussive pain: a randomized controlled trial of symptom treatment in the emergency department. Pediatr Emerg Care 30:139–145. https://doi.org/10.1097/PEC.0000000000000084
Rosenbaum PE, Locandro C, Chrisman SPD et al (2020) Characteristics of pediatric mild traumatic brain injury and recovery in a concussion clinic population. JAMA Netw Open 3:e2021463. https://doi.org/10.1001/jamanetworkopen.2020.21463
Meehan WP, Mannix R, Monuteaux MC et al (2014) Early symptom burden predicts recovery after sport-related concussion. Neurology 83:2204–2210. https://doi.org/10.1212/WNL.0000000000001073
Rytter HM, Graff HJ, Henriksen HK et al (2021) Nonpharmacological treatment of persistent postconcussion symptoms in adults: a systematic review and meta-analysis and guideline recommendation. JAMA Netw Open 4:e2132221. https://doi.org/10.1001/jamanetworkopen.2021.32221
Author information
Authors and Affiliations
Contributions
All authors contributed to the study conception and design. Literature search and data analysis were performed by Damla Hanalioglu and Sahin Hanalioglu. The first draft of the manuscript was written by Damla Hanalioglu and Sahin Hanalioglu and all authors commented on previous versions of the manuscript. Jorge Arango and David Adelson critically revised the work. All authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Ethics approval
This is a systematic review of the current literature. Authors declare that PRISMA guidelines were followed when preparing the manuscript.
Consent
N/A.
Competing interests
The authors declare no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Hanalioglu, D., Hanalioglu, S., Arango, J.I. et al. Current evidence for pharmacological management of pediatric concussion: a systematic review. Childs Nerv Syst 39, 1831–1849 (2023). https://doi.org/10.1007/s00381-023-05960-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00381-023-05960-x